...
首页> 外文期刊>Medicine. >Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case–Control Study in a Finnish Population—The TAMRISK Study
【24h】

Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case–Control Study in a Finnish Population—The TAMRISK Study

机译:功能性诱导型一氧化氮合酶基因变异与高血压相关:芬兰人群的病例对照研究— TAMRISK研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Increased inducible nitric oxide synthase (iNOS) activity and expression has been associated with hypertension, but less is known whether the 2 known functional polymorphic sites in the iNOS gene (g.–1026 C/A (rs2779249), g.2087 G/A (rs2297518)) affect susceptibility to hypertension. The objective of this study was to investigate the association between the genetic variants of iNOS and diagnosed hypertension in a Finnish cohort. This study included 320 hypertensive cases and 439 healthy controls. All participants were 50-year-old men and women and the data were collected from the Tampere adult population cardiovascular risk study (TAMRISK). DNA was extracted from buccal swabs and iNOS single nucleotide polymorphisms (SNPs) were analyzed using KASP genotyping PCR. Data analysis was done by logistic regression. At the age of 50 years, the SNP rs2779249 (C/A) associated significantly with hypertension ( P = 0.009); specifically, subjects carrying the A-allele had higher risk of hypertension compared to those carrying the CC genotype (OR = 1.47; CI = 1.08–2.01; P = 0.015). In addition, a 15-year follow-up period (35, 40, and 45 years) of the same individuals showed that carriers of the A-allele had more often hypertension in all of the studied age-groups. The highest risk for developing hypertension was obtained among 35-year-old subjects (odds ratio [OR] 3.83; confidence interval [CI] = 1.20–12.27; P = 0.024). Those carrying variant A had also significantly higher readings of both systolic ( P = 0.047) and diastolic ( P = 0.048) blood pressure during the follow-up. No significant associations between rs2297518 (G/A) variants alone and hypertension were found. However, haplotype analysis of rs2779249 and rs2297518 revealed that individuals having haplotype H3 which combines both A alleles (CA–GA, 19.7% of individuals) was more commonly found in the hypertensive group than in the normotensive group (OR = 2.01; CI = 1.29–3.12; P = 0.002). In conclusion, there was a significant association between iNOS genetic variant (rs2779249) and hypertension in the genetically homogenous Finnish population. Those who carried the rare A-allele of the gene had higher risk for hypertension already at the age of 35 years.
机译:诱导型一氧化氮合酶(iNOS)活性和表达增加与高血压相关,但对于iNOS基因中2个已知的功能性多态性位点(g.–1026 C / A(rs2779249),g.2087 G / A)知之甚少(rs2297518))影响高血压的易感性。这项研究的目的是调查芬兰人群中iNOS遗传变异与确诊的高血压之间的关系。这项研究包括320例高血压病例和439例健康对照者。所有参与者均为50岁的男性和女性,数据来自坦佩雷成人人群心血管风险研究(TAMRISK)。从颊拭子中提取DNA,并使用KASP基因分型PCR分析iNOS单核苷酸多态性(SNP)。数据分析通过逻辑回归进行。在50岁时,SNP rs2779249(C / A)与高血压显着相关(P = 0.009);具体而言,与携带CC基因型的受试者相比,携带A等位基因的受试者有更高的高血压风险(OR = 1.47; CI = 1.08–2.01; P = 0.015)。此外,对同一个体进行的15年随访期(35、40和45年)显示,在所有研究的年龄组中,A等位基因携带者的血压更高。在35岁的受试者中,患高血压的风险最高(几率[OR] 3.83;置信区间[CI] = 1.20–12.27; P = 0.024)。在随访期间,携带变体A的患者的收缩压(P = 0.047)和舒张压(P = 0.048)的读数也明显较高。没有发现单独的rs2297518(G / A)变体与高血压之间有显着关联。但是,对rs2779249和rs2297518的单倍型分析显示,与正常血压组相比,在高血压组中更常见具有合并了两个A等位基因的单倍型H3的个体(CA-GA,占个体的19.7%)(OR = 2.01; CI = 1.29) –3.12; P = 0.002)。总之,在芬兰同基因人群中,iNOS基因变异(rs2779249)与高血压之间存在显着关联。那些携带该基因罕见的A等位基因的人在35岁时就有较高的高血压风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号